ONCOSEC MEDICAL INCORPORATED

(ONCS)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
0.7409 USD   -0.28%
07/12ONCOSEC MEDICAL INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/24Novel pre-clinical results regarding OncoSec's intratumoral electroporation platform were highlighted as Editor's Pick in Molecular Cancer Research
PR
06/14ONCOSEC MEDICAL INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

OncoSec Medical Names Robert Arch CEO; Shares Rise Early

04/29/2022 | 05:10pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
GSK PLC 3.57% 1450 Delayed Quote.-14.82%
NOVARTIS AG -1.16% 80.1 Delayed Quote.0.95%
ONCOSEC MEDICAL INCORPORATED -0.28% 0.7409 Delayed Quote.-22.57%
PFIZER, INC. 3.77% 50.11 Delayed Quote.-18.22%
TAKEDA PHARMACEUTICAL COMPANY LIMITED 0.42% 3798 Delayed Quote.20.56%
All news about ONCOSEC MEDICAL INCORPORATED
07/12ONCOSEC MEDICAL INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/24Novel pre-clinical results regarding OncoSec's intratumoral electroporation platform we..
PR
06/14ONCOSEC MEDICAL INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RE..
AQ
06/14OncoSec Medical Incorporated Reports Earnings Results for the Third Quarter and Nine Mo..
CI
06/09ONCOSEC MEDICAL INC : Other Events (form 8-K)
AQ
06/09OncoSec Medical Incorporated Appoints Joon Kim to the Audit Committee
CI
06/03ONCOSEC MEDICAL INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule o..
AQ
05/23OncoSec Receives Triple Negative Breast Cancer Foundation's Vanguard Award for Excellen..
PR
04/29OncoSec Medical Names Robert Arch CEO; Shares Rise Early
MT
04/29ONCOSEC MEDICAL INCORPORATED : Appoints Dr. Robert Arch as President and Chief Executive O..
PU
More news
Analyst Recommendations on ONCOSEC MEDICAL INCORPORATED
More recommendations
Financials (USD)
Sales 2022 - - -
Net income 2022 -35,7 M - -
Net Debt 2022 - - -
P/E ratio 2022 -0,82x
Yield 2022 -
Capitalization 29,2 M 29,2 M -
Capi. / Sales 2022 -
Capi. / Sales 2023 -
Nbr of Employees 56
Free-Float 44,1%
Chart ONCOSEC MEDICAL INCORPORATED
Duration : Period :
OncoSec Medical Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ONCOSEC MEDICAL INCORPORATED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 0,74 $
Average target price 5,00 $
Spread / Average Target 575%
EPS Revisions
Managers and Directors
Robert H. Arch President & Chief Executive Officer
George Chi Chief Financial Officer
Linda Shi Chairman
Sandra Aung Chief Clinical Development Officer & Senior VP
Keir Loiacono Chief Compliance Officer & Vice President-Legal
Sector and Competitors
1st jan.Capi. (M$)
ONCOSEC MEDICAL INCORPORATED-22.57%29
MODERNA, INC.-32.35%67 212
LONZA GROUP AG-23.32%46 073
IQVIA HOLDINGS INC.-14.23%45 135
SEAGEN INC.12.57%32 099
ALNYLAM PHARMACEUTICALS, INC.35.27%27 533